MentionFox
Home › Layoffs › Tempest Therapeutics, Inc.
SEC filings · Form 8-K, Item 2.05

Tempest Therapeutics, Inc. layoffs and restructuring

Before you join, sell to or invest in Tempest Therapeutics, Inc.

MentionFox check on Tempest Therapeutics, Inc.: only 2 sources on file so far (checked 15 November 2026). Run a full check before you rely on it. mentionfox.com/c/layoffs/tempest-therapeutics

  • Note: Layoff plan disclosed Apr 2025 (about 26 employees) (filing)

New since last check: Layoff plan disclosed Apr 2025 (about 26 employees) (filing, first seen 14 November 2026).

Check Tempest Therapeutics, Inc. before you join, sell or invest Free, no sign-up: every record on file, each linked to its source.

What do you want to do about Tempest Therapeutics, Inc.?

Every exit or restructuring plan Tempest Therapeutics, Inc. reported on Form 8-K under Item 2.05: the filing's own words on employees affected, share of workforce, locations, charges and timing.

About 26 employees are affected, according to Tempest Therapeutics, Inc.'s latest layoff filing, on April 18, 2025. Tempest Therapeutics, Inc. trades on Nasdaq as TPST; it was formerly Millendo Therapeutics, Inc. As of November 15, 2026, Tempest Therapeutics, Inc. has reported this one exit or restructuring plan to the SEC on Form 8-K under Item 2.05 (Form 8-K, April 18, 2025).

10 companies announced layoffs this week, 1 had other signals.

Companies cutting jobs this week. Before you unlock: the company, the number of employees and what is inside. After: every way we found to reach the company. No individual is named in a layoff.

UPWORK, INCannounced layoffs
PVH CORP. /DE/announced layoffs
Battellefiled a layoff notice for 15 employees
TidalHealth Primary Carefiled a layoff notice for 5 employees
Phunware, Inc.announced layoffs
Check one company free All companies that announced layoffs this week

Versant Venture Capital VI, L.P. also filed stake reports on 3 other companies ↓

Is this your company?

Owed money by them or selling to them? See the free Snapshot of Tempest Therapeutics, Inc.

Free to see. No signup.

People from Tempest Therapeutics, Inc. who say they are open to work

Only people who added themselves are listed here. Nobody is named because of a company announcement or a news story, and we have not checked what anyone says about themselves.

Loading the list…

Affected by the Tempest Therapeutics, Inc. layoff? Add yourself to the open-to-work list, free
SEC filings1
Latest, employees26
Latest filing2025-04-18

Tempest Therapeutics, Inc. reported 1 exit or restructuring plan on Form 8-K under Item 2.05, 1 of 1 stating how many employees or positions are affected. Each fact below is the filing's own sentence, quoted and linked. No WARN notice under this company's name is on file in the states covered here.

Did Tempest Therapeutics have layoffs in 2025? What its filings say

Tempest Therapeutics, Inc. (CIK 1544227) reported 1 exit or restructuring plan to the SEC on Form 8-K under Item 2.05. The sentences below are quoted from the filings as written.

Form 8-K filed 2025-04-18

Employees affected

As part of the plan, the Company will reduce its workforce by 21 of 26 full-time employees, effective April 30, 2025.

Expected charges

The Company estimates that it will incur approximately $1.5 million of cash expenditures, consisting primarily of one-time severance payments, benefits and other related costs (excluding non-cash charges associated with equity-based compensation), with the majority of such costs to be incurred in the second quarter of 2025.

Also on the record for Tempest Therapeutics, Inc.

DateRecordFigureOur pageSource
October 30, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
October 19, 2026Leadership change: John Frederick appointed, Director—Leadership changesSource
October 14, 2026Form D, private offering$7.50M soldForm D pageSource
September 28, 2026Leadership change: Constance Ames appointed, Chief Financial Officer—Leadership changesSource
August 24, 2026Leadership change: Nicholas Rossettos appointed, Chief Financial Officer—Leadership changesSource
June 23, 2026Form D, private offering$4.06M soldForm D pageSource
June 4, 2026Leadership change: Justin Trojanowski appointed, Vice President, Finance—Leadership changesSource
May 29, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
May 22, 2026Leadership change filing (Form 8-K, Item 5.02)—Leadership changesSource
April 3, 2026Form D, private offering$2M soldForm D pageSource
April 2, 2026Stake report, Schedule 13D/A, by Versant Venture Capital VI, L.P.1.1% of the class5%+ stakesSource
March 25, 2026Stake report, Schedule 13D/A, by Matthew Angel37.4% of the class5%+ stakesSource

Keep reading

More on Tempest Therapeutics, Inc. and the records around it.

Tempest Therapeutics, Inc. elsewhere on the record

Companies that share a holder

What do you want to do with Tempest Therapeutics, Inc.?

Want the whole picture on Tempest Therapeutics, Inc.?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Tempest Therapeutics, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Tempest Therapeutics, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    13 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The newest 12 of 16 records.

Tools for this story

Each opens in a new tab, filled in for Tempest Therapeutics, Inc.. With no account yet, you sign up free and land on the result.

Public companies must also report to the SEC, on Form 8-K under Item 2.05, when they commit to an exit or restructuring plan that will cost them material charges, which is how most large layoffs and closures by listed companies are disclosed. Those filings are national, so they cover companies in every state. Each sentence shown from one is quoted exactly and linked to the filing; where a filing does not state a figure, none is shown.

Where this comes from

Employers covered by the federal WARN Act, and by the stricter laws some states add, must give written notice before a mass layoff or a site closure. The state labor department publishes those notices. Every row here is one of them, taken from that state's own published file and linked to it, so each figure can be checked at the source.

A notice states the employer, the location, the number of employees affected, and when the layoff or closure takes effect. It does not state a reason, and neither does this page. Where a company also appears in SEC filings under the same name and in the same state, its recorded fundraising is shown alongside, as a matter of record rather than as an explanation. New Jersey and Pennsylvania list a notice under the month it was posted or received, not the day, so their notices show a month. Tennessee gives the county rather than the city.

Cite this page

Permanent URL: https://mentionfox.com/layoffs/tempest-therapeutics
Last updated 2026-11-15
Tempest Therapeutics, Inc. layoffs 2025: about 26 jobs (8-K). MentionFox, 2026-11-15. https://mentionfox.com/layoffs/tempest-therapeutics